Varenicline: all 249 studies that test it
Page 3 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)CompletedNCT01387425Not applicable
- Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive ImpairmentWithdrawnNCT01309685Phase 1
- Influence of Varenicline on the Antiplatelet Action of ClopidogrelStatus unknownNCT01308671Not applicable
- Varenicline in Drug TreatmentCompletedNCT01286584Phase 4
- Tailoring Varenicline to Individual Needs (TVIN Study)CompletedNCT01206010Phase 3
- Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary SyndromeStatus unknownNCT01170338Phase 4
- Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine ReinforcementWithdrawnNCT01143857Phase 2
- Smoking Termination Opportunity for inPatientsCompletedNCT01141855Phase 2/3
- Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar DisorderCompletedNCT01093937Not applicable
- Effect of Varenicline on Cognitive Function in Cigarette Smokers With SchizophreniaCompletedNCT01093365Phase 2
- Varenicline for Alcohol DependenceStatus unknownNCT01071187Phase 2
- Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3CompletedNCT00992771Phase 2
- Varenicline for Long-term Nicotine Replacement Therapy (NRT) UsersStatus unknownNCT00977249Phase 2/3
- Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart DiseaseCompletedNCT00959972Phase 4
- Effects of Chantix on Relapse Prevention for Smoking CessationCompletedNCT00948649Phase 4
- Smoking Cessation Program in the Preadmission ClinicStatus unknownNCT00937508Phase 4
- Smoking Cessation Treatment for Head and Neck Cancer PatientsTerminatedNCT00931021Early Phase 1
- Efficacy and Safety of Varenicline Among HIV-infected PatientsCompletedNCT00918307Phase 3
- Methadone Maintenance Treatment and Smoking CessationStatus unknownNCT00906386Phase 2
- Assessing the Impact of Varenicline on Brain-Behavior VulnerabilityWithdrawnNCT00895557Phase 2
- Effect of Varenicline on Reactivity to Smoking and Drinking CuesCompletedNCT00873535Not applicable
- Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?CompletedNCT00846859Phase 2
- Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's AtaxiaTerminatedNCT00803868Phase 2/3
- Treating Schizophrenic Smokers: Effects on Craving, Cues and WithdrawalWithdrawnNCT00781755Phase 4
- A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With SchizophreniaWithdrawnNCT00743847Phase 2
- Varenicline-Methamphetamine Interaction Study (2008)WithdrawnNCT00733967Phase 1
- Varenicline Treatment in Alcohol and Nicotine Dependent Patients With SchizophreniaCompletedNCT00727103Phase 4
- Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
- Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking SubjectsCompletedNCT00694044Phase 1
- A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.CompletedNCT00661765Phase 1
- A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit SmokingCompletedNCT00635401Phase 2
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit AttemptWithdrawnNCT00571805Phase 1/2
- Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult SmokersCompletedNCT00527150Phase 1
- Mood and Anti-craving Effects of Varenicline in Psychiatric InpatientsWithdrawnNCT00525928Not applicable
- The Effects of Varenicline on Cognitive Function in Patients With SchizophreniaCompletedNCT00523445Phase 3
- A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent SmokersCompletedNCT00463918Phase 1
- Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking VolunteersCompletedNCT00452894Phase 1
- An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit SmokingCompletedNCT00371813Phase 3
- Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop SmokingCompletedNCT00301145Not applicable
- 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.CompletedNCT00150254Phase 2
- A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking CessationCompletedNCT00150241Phase 2
- 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking CessationCompletedNCT00150228Phase 2
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking CessationCompletedNCT00143364Phase 3
- An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking CessationCompletedNCT00143325Phase 3
- A 52-Week Placebo-Controlled Study Evaluating the Safety of VareniclineCompletedNCT00143299Phase 3
- A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking CessationCompletedNCT00143286Phase 3
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking CessationCompletedNCT00141206Phase 3
- A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking CessationCompletedNCT00141167Phase 3
- 12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking CessationCompletedNCT00139750Phase 2